News and insights

Search all news & insights

    Latest news

    Show
    news from

    Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel - obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

    Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations

    Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

    Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress

    Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer

    Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024

    View all news

    Latest insights & articles

    Show
    insights & articles from

    Sorry, we can't find any insights or articles

    View all insights & articles

    Latest publications & presentations

    Show presentations from

    Autolus Corporate Presentation - September 2024

    Download PDF (1.71Mb)

    Autolus Corporate Presentation - June 2024

    Download PDF (1.64Mb)

    Autolus Corporate Presentation - November 2023

    Download PDF (2.23Mb)

    Autolus Corporate Presentation - July 2023

    Download PDF (1.82Mb)

    Autolus Corporate Presentation - March 2023

    Download PDF (1.58Mb)

    Autolus Corporate Presentation - January 2023

    Download PDF (1.57Mb)
    View all publications & presentations

    Search